New drug safety study in healthy volunteers halted before it began
NCT ID NCT03995550
First seen May 05, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study was designed to test the safety and tolerability of a new drug called LEO 142397 in healthy volunteers. It was planned in two parts: a single dose and daily doses for 14 days. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Covance Clinical Research Unit Ltd.
Leeds, LS2 9LH, United Kingdom
Conditions
Explore the condition pages connected to this study.